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To investigate associations between retinal microvascular changes and cognitive




A primary care cohort with newly diagnosed type 2 diabetes mellitus.
Methods
For this analysis, we compared 69 cases with lowest decile scores (for the cohort) on the
Modified Telephone Interview for Cognitive Status and 68 controls randomly selected from
the remainder of the cohort. Retinal images were rated and the following measures com-
pared between cases and controls: retinal vessel calibre, arterio-venous ratio, retinal fractal
dimension, and simple and curvature retinal vessel tortuosity.
Results
Total and venular (but not arteriolar) simple retinal vessel tortuosity levels were significantly
higher in cases than controls (t = 2.45, p = 0.015; t = 2.53, p = 0.013 respectively). The asso-
ciations persisted after adjustment for demographic factors, retinopathy, neuropathy, obe-
sity and blood pressure. There were no other significant differences between cases and
controls in retinal measures.
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Conclusions
A novel association was found between higher venular tortuosity and cognitive impairment
in newly diagnosed type 2 diabetes mellitus. This might be accounted for by factors such as
hypoxia, thrombus formation, increased vasoendothelial growth factor release and inflam-
mation affecting both the visible retinal and the unobserved cerebral microvasculature.
Introduction
Type 2 diabetes mellitus (T2DM) is associated with a range of adverse consequences, including
a higher risk of cognitive impairment and dementia, which is increasingly becoming recognised
[1–3]. It has been estimated that the risk of developing Alzheimer’s disease is doubled and that
of vascular dementia tripled in T2DM [4]. The pathways underlying these associations may be
multiple. Pre-diabetes factors such as obesity, or other co-morbidities such as hypertension
and dyslipidemia, may play a role, and diabetic effects on large and small vessels serving the
brain are also likely [5].
Retinal microvascular abnormalities in T2DM range from mild, non-proliferative changes
to proliferative diabetic retinopathy, and reflect the severity of the condition and the degree of
glycemic control. [6]. Retinal vasculature shares embryological origins, physiological character-
istics, structure and size with cerebral vasculature [7, 8], and thus provides a potential means to
investigate further the relationship between diabetes and cognitive function. Investigations into
associations between retinal imaging measurements and cognitive function in T2DM have
been relatively few. Kadoi and colleagues [9] found that diabetic retinopathy was associated
with cognitive impairment 6 months after coronary artery bypass surgery, and Ding and col-
leagues [10] found that diabetic retinopathy was independently associated with lifetime cogni-
tive decline in older men. However, a recent study by Crosby-Nwaobi and colleagues [11]
found that people with proliferative diabetic retinopathy had less cognitive impairment than
those with mild or no retinopathy, suggesting that the increased incidence of cognitive
impairment in T2DMmay be due to other factors rather than microvascular disease reflected
in the retina.
A limitation with previous research in this field has been that T2DM cases often include
people with long diabetes duration which might give rise to obscured relationships due to selec-
tive survival, as well as confounding by other factors co-occurring during disease progression.
In a sample of newly-diagnosed T2DM we sought to compare measurements derived from reti-
nal imaging between people with and without cognitive impairment close to the disease onset.
Materials and Methods
Cases and Controls
The analysed samples were drawn from baseline participants in the South London Diabetes
Study (SOUL-D), an ongoing prospective study of people with newly diagnosed T2DM [12].
Ethical approval was granted by the King’s College Hospital Research Ethics Committee (refer-
ence 08/H0808/1) and by Lambeth, Southwark and Lewisham Primary Care Trusts (reference
RDLSLB 410) and all participants gave written informed consent, including access to their
medical records. The SOUL-D study was carried out to identify individuals with newly diag-
nosed T2DM in order to investigate associations of a range of biopsychosocial factors with bio-
medical outcomes over a 2-year period. The setting comprised adjacent London boroughs of
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Lambeth, Southwark and Lewisham–a multi-ethnic and socioeconomically diverse catchment
population of approximately 0.75 million residents–and the sampling frame included all 138
general practices in this area, 96 of which agreed to participate. Participants were aged 18–75
years and recruited from these primary care centres. All participants had been diagnosed with
T2DM within the last six months. Exclusion criteria comprised: i) diabetes other than T2DM;
ii) temporary residence and/or residence outside the catchment area; iii) lack of fluency in
English; iv) movement from another primary care team; v) a terminal or separate advanced
condition; vi) severe mental illness (dementia, substance dependence, bipolar disorder, person-
ality disorder); and vii) severe advanced complications of diabetes (blindness, requiring dialysis
or having undergone an above-the-knee amputation). Of 1200 participants recruited at the
time of the analyses carried out for this paper, 1084 (90.3%) had received cognitive assessment
using the modified Telephone Interview for Cognitive Status (TICSM), a widely used measure
of global cognitive function [13, 14]. For this study, cases were defined as SOUL-D participants
with TICSM scores in the lowest 10% of the sample distribution (score 17 or below), and a ran-
domly selected sample of remaining participants were identified as controls. Case/control sta-
tus was blinded on the database until retinal measurements had been carried out. Retinal
imaging had been performed on all SOUL-D participants at baseline, but vascular parameters
had not been measured. Because of limited resource for vascular measurements, a case control
approach was felt to be most time-efficient, comparing participants with and without cognitive
impairment. Retinal images were therefore retrieved for further grading, with continued sam-
pling from the SOUL-D database carried out until images of sufficient quality were available
for 69 cases and 68 controls.
Measurements
Retinal photography had been performed following a standardized protocol [15]. In brief, ste-
reoscopic retinal photographs, after pupil dilation, were taken of both eyes from patients on
the SOUL-D database, using a Topcon Fundus Camera (TRC 50-VT; Tokyo Optical, Tokyo,
Japan). Retinal images were graded by Singapore I Vessel Assessment (SIVA), a semi-auto-
mated program developed at the National University of Singapore. Excluded images were
those with incomplete representation of Zone C or excessive blurring, or if there were fewer
than four arterioles or venules that could be graded. The retinal images selected were those of
best quality from either the right or left eye and were the closest taken to within 6 months of
the date of recruitment to SOUL-D. SIVA automatically detected the optical disc if the image
was of sufficient quality; otherwise a trained grader manually detected it. After optical disc
identification, SIVA constructed a grid with three concentric subzones, 0.5 (zone A), 1.0 (zone
B) and 2.0 (zone C) optic disc diameters from the optic disc margin at the centre. The grader
then commanded the program to find all vessels, and arterioles and venules were detected.
SIVA traced the vessel using its centreline, from zone B to zone C (Fig 1). SIVA has an ability
of 70–90% of detecting appropriate arterioles and vessels [16], but if the grader deemed the
detection of vessels false or inaccurate, they were manually corrected. This was based on parent
vessels, and cross-over and colour of vessels. The grading of each image took approximately
1–1.5 hours. The grader was trained and tested by a senior grader. Inter-and intra-grader reli-
ability for retinal measurements, tested with 10 random images, gave interclass correlation
coefficients ranging from 0.88–0.99.
The measurements made were retinal vessel caliber, arterio-venous ratio, retinal fractal
dimension and retinal vessel tortuosity. Retinal vessel calibers were defined via the central arte-
riole equivalent and central venule equivalent as described by the Parr-Hubbard-Knudtson for-
mula [17] and the arterio-venous ratio was calculated from the ratio between these respective
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measures. These measurements were based on the widest six arterioles and venules. The retinal
fractal dimension, quantifying the degree of complexity of the branching of the retinal vascula-
ture [18], was calculated for all vessels, and then separately for arterioles and venules. Retinal
tortuosity [19] was measured by SIVA in two respects: i) simple tortuosity, based on estimating
the difference between the actual length of the vessel segment, incorporating the curves, and
the straight length of the vessel segment, divided by the straight length of the vessel segment
(i.e. arc length/chord length); ii) curvature tortuosity, based on vessel curvature and, unlike
simple tortuosity, taking into account increased length due to bowing and multiple points of
inflexion (calculated from the integral of the curvature square along the vessel path, normalised
by the total length of the path) [20]. Simple and curvature tortuosity were quantified for all ves-
sels with a width larger than 40 μm coursing through from Zone B to Zone C, and for arterioles
and venules separately.
Covariates obtained from baseline SOUL-D examinations and used in this analysis com-
prised the following: age, sex, ethnicity (white, black, Asian/other), body mass index, resting
Fig 1. Colour and grey-scale fundus photographs of two different eyes analysed by SIVA. (A) Colour
fundus photograph showing optic disc, three concentric subzones, and arterioles and venules, with vessel
data. (B) Grey-scale fundus photograph with screen showing multiple measurements of the diameter of the
highlighted vessel and vessel data.
doi:10.1371/journal.pone.0147160.g001
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systolic and diastolic blood pressure, receipt of antihypertensive medication, retinopathy
(defined as any retinal haemorrhage or microaneurysm found in either eye by an ophthalmolo-
gist), neuropathy (defined on the basis of a vibration perception threshold score of 25 or more)
and HbA1c.
Statistical Analysis
Cases and controls were first described in relation to covariates. Mean and standard deviation
(SD) scores for retinal vessel measures were then compared between the two groups, using t-
tests to assess levels of statistical significance. Significant and near-significant (p<0.10) differ-
ences were then assessed further for independence in sequentially adjusted linear regression
models: adjusting first for demographic factors (age, sex, ethnicity); next for retinopathy, neu-
ropathy and BMI; next for blood pressure and antihypertensive medication; and finally for
HbA1c. All analyses were carried out using Statistical Package of the Social Sciences (SPSS)
software, version 20.
Results
Sample characteristics are summarised in Table 1. Cases were significantly more likely to be
female but there were no other significant differences.
Retinal measures are compared between the case and control groups in Table 2. There were
significantly higher simple total and venular tortuosity measures in cases compared to controls
but no differences in other measures.
In multivariable models (Tables 3 & 4), the associations with greater simple venular and
total tortuosity persisted and were largely unaltered following adjustment for covariates. To
Table 1. Sample characteristics.
Characteristic Percentage/mean (SD) Chi-square (df) or t-statistic, p-value
Controls (n = 68) Cases (n = 69)




Female sex (%) 35.3 55.1 5.4 (1), 0.020
Ethnic group (%) White 51.5 42.0 1.7 (2), 0.42
Black 36.8 47.8
Asian/Other 11.8 10.1




Antihypertensive medication (%) 43.3 49.3 0.5 (1), 0.49
Neuropathy present (%) 11.8 13.0 0.5 (1), 0.82
Retinopathy present (%) 11.9 22.4 2.6 (1), 0.11
Mean (SD) systolic blood pressure
(mmHg)
137 (13.7) 136 (19.7) 0.27, 0.788
Mean (SD) diastolic blood pressure
(mmHg)
83 (9.5) 81 (9.9) 1.25, 0.213
Mean (SD) HbA1c (%) 6.9 (1.1) 7.2 (1.6) 1.1, 0.264
doi:10.1371/journal.pone.0147160.t001
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investigate further age as a potential confounder, we analysed associations with these outcomes
in the combined samples of cases and controls, modelling the simple tortuosity measures as
dependent variables in linear regression analyses with age as the independent variable; in sum-
mary, associations with older age were, if anything, negative rather than positive and were not
substantial in strength (for 10-year age increments with simple arteriolar tortuosity: B -0.004,
95% CI -0.008 to 0, p = 0.052; with simple venular tortuosity: B -0.001, 95% CI -0.005 to 0.003,
p = 0.489; with simple total tortuosity: B -0.003, 95% CI -0.006 to 0, p = 0.087).
Discussion
In this case control study carried out within a sample of people with newly diagnosed type 2
diabetes, participants with cognitive impairment (defined as the 10% lowest scores on a com-
monly used test of global function) and randomly selected controls from the same cohort were
identified. A series of measurements derived from retinal imaging was then compared between
the two groups, ascertained blind to case/control status. While most retinal image measures
did not differ between the comparison groups, simple vessel tortuosity was higher in cases than
controls, an association which reflected higher simple venular, rather than arteriolar, tortuos-
ity. To our knowledge, this is a novel finding.
Table 2. Retinal vascular marker distributions in cases and controls.
Retinal vascular marker Mean (SD) in Controls (n = 68) Mean (SD) in Cases (n = 69) Mean difference (95% CI) t-statistic (p-value)
Arteriolar calibre 146.9 (18.5) 150.3 (15.6) 3.3 (-2.4, 9.1) 1.14 (0.26)
Venular calibre 216.9 (26.5) 218.6 (22.2) 1.7 (-6.6, 9.9) 0.40 (0.69)
Arteriovenous ratio 0.68 (0.06) 0.69 (0.05) 0.01 (-0.01, 0.03) 1.07 (0.29)
Fractal Dimension:
Arterioles 1.22 (0.06) 1.23 (0.06) 0.01 (-0.01, 0.03) 0.95 (0.35)
Venules 1.20 (0.05) 1.21 (0.05) 0.01 (-0.01, 0.03) 1.37 (0.17)
Total 1.43 (0.05) 1.44 (0.05) 0.01 (-0.01, 0.03) 1.38 (0.17)
Simple Tortuosity:
Arterioles 1.100 (0.02) 1.107 (0.03) 0.006 (-0.003, 0.015) 1.27 (0.21)
Venules 1.102 (0.02) 1.114 (0.03) 0.012 (0.002, 0.021) 2.53 (0.013)
Total 1.102 (0.02) 1.110 (0.02) 0.009 (0.002, 0.016) 2.45 (0.015)
Curvature Tortuosity (x106)
Arterioles 74.0 (32.6) 71.6 (31.2) -2.5 (-13.2, 8.4) -0.44 (0.66)
Venules 78.5 (30.5) 80.4 (21.1) 1.9 (-6.9, 10.8) 0.43 (0.67)
Total 76.4 (27.5) 76.1 (24.6) -0.3 (-9.1, 8.5) -0.06 (0.95)
doi:10.1371/journal.pone.0147160.t002
Table 3. Linear regression analysis of the association between cognitive impairment and simple
venular tortuosity.
Sequential adjustments B-coefﬁcient (95%
CI)
Unadjusted 0.012 (0.003, 0.021)
Adjusted for age, sex, ethnic group 0.012 (0.002, 0.021)
Further adjusted for retinopathy, neuropathy, BMI 0.013 (0.003, 0.023)
Further adjusted for systolic blood pressure, diastolic blood pressure and
antihypertensive medication
0.014 (0.003, 0.024)
Further adjusted for HbA1c 0.013 (0.002, 0.025)
doi:10.1371/journal.pone.0147160.t003
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The strengths of the study are that cases and controls were drawn from the same source
sample, limiting the likelihood of selection bias, and the blind ascertainment of retinal mea-
sures, reducing information bias. A range of potential confounding factors were considered,
but did not appear to account for the associations found (and age, specifically, was not associ-
ated with either of the outcomes found to be associated with cognitive impairment). In consid-
ering the findings, it is important to bear in mind that the source SOUL-D study recruited
people newly diagnosed with T2DM. This was methodologically advantageous in minimising
the likelihood of confounding and/or reverse causality relating to longer-lasting or more
advanced diabetes. However, generalisability cannot be assumed to people with diabetes of lon-
ger duration; for example, it is possible that the negative findings for retinopathy and some of
the retinal measures might have been a result of the restriction to newly diagnosed cases. Con-
sidering other limitations, the case and control sample sizes were relatively small, and absent
associations should be treated with caution as there might have been smaller but clinically rele-
vant differences which the study did not have statistical power to identify. It should also be
borne in mind that simple venular and total tortuosity were only two of twelve measures ana-
lysed which differed significantly between cases and controls, and that the findings although
plausible require replication.
In our study, although twice as many cases compared to controls had clinically recognised
retinopathy, the numbers in this cohort were small in both groups, and the association between
simple venular tortuosity and cognitive impairment remained significant after adjustment, sug-
gesting that vessel tortuosity was not simply a marker of retinopathy. While one recent study
found that venular and arteriolar curvature tortuosity was decreased in proliferative diabetic
retinopathy [21], no association was found in another between venular tortuosity and diabetic
retinopathy [22]. Our observation may therefore indicate a different underlying mechanism.
Hypertension has also been found to be associated with increased venular tortuosity [23],
shares risk pathways with diabetes [24], and is an independent risk factor for cognitive decline
and dementia [25]. However, there was no significant difference in blood pressure levels
or treated hypertension between cases and controls in our study, and adjustment for these fac-
tors had little impact on the association between simple venular tortuosity and cognitive
impairment.
Our finding that curvature venous tortuosity showed no association with increasing levels
of cognitive impairment is potentially anomalous as it is considered a more robust measure of
vessel tortuosity than simple tortuosity, taking into account increased length due to bowing
and multiple points of inflection [20]. Despite this, there are still potential reasons why
increased simple tortuosity alone might link with cognitive impairment. One of these is that
venular tortuosity might reflect underlying hypoxia. Retinal venular tortuosity has been found
to be increased in high altitude conditions [26, 27], potentially because of increased shear stress
Table 4. Linear regression analysis of the association between cognitive impairment and simple total
tortuosity.
Sequential adjustments B-coefﬁcient (95%
CI)
Unadjusted 0.009 (0.002, 0.016)
Adjusted for age, sex, ethnic group 0.009 (0.002, 0.017)
Further adjusted for retinopathy, neuropathy, BMI 0.009 (0.001, 0.016)
Further adjusted for systolic blood pressure, diastolic blood pressure and
antihypertensive medication
0.010 (0.002, 0.018)
Further adjusted for HbA1c 0.011 (0.003, 0.020)
doi:10.1371/journal.pone.0147160.t004
Retinal Markers of Microvascular Disease and Cognitive Impairment in Newly Diagnosed Type 2 Diabetes
PLOS ONE | DOI:10.1371/journal.pone.0147160 January 15, 2016 7 / 11
causing elongation of vessel segments [27] as a result of increased blood flow to correct local
hypoxia. In diabetes, hyperglycemia may cause hypoxia by various mechanisms such as vaso-
constriction, leucostasis and induction of a pro-inflammatory state [28], as well as by disrupt-
ing blood flow via vascular endothelial and basement membrane disruption [29]. Therefore
brain hypoxia causing cognitive impairment in diabetes might also result in venular tortuosity
visible in retinal imaging. Venular tortuosity has also been found to be associated with
increased venous thrombus formation and small venule strokes [30], which may in turn lead to
decreased blood flow and brain and cognitive dysfunction [31]. Both hypoxia and hyperglyce-
mia are associated with increased vasoendothelial growth factor release, which stimulates vas-
culogenesis and angiogenesis in response to hypoxia [32]; these processes might initiate retinal
changes in early diabetes, localized to the venules and capillaries of the superficial inner retinal
vasculature [33], resulting in venular tortuosity [34], and may increase vascular permeability
[35], leading to protein extravasation, chronic edema and tissue necrosis. Finally, increased
high-sensitivity C-reactive protein has been found to be associated with increased retinal venu-
lar tortuosity [36] and the finding might thus reflect an underlying pro-inflammatory state
implicated in T2DM [37], cognitive decline [38] and dementia [39], separate from
hyperglycaemia.
Our findings suggest at least a link, whether causal or not, between retinal microvascular
change and cognitive impairment in T2DM. A recent review concluded that retinal microvas-
cular changes showed consistent and moderately strong associations in cross-sectional studies
with dementia, with relative cognitive impairment in people without dementia, and with brain
imaging abnormalities [40]. On the other hand, the few longitudinal studies only showed mar-
ginal associations with dementia or cognitive decline, but more consistent links with progres-
sion of brain imaging abnormalities: relatively weak for vascular caliber measurements,
intermediate for arteriovenous nicking and focal narrowing, and strong for retinopathy. These
associations were also stronger in people with both hypertension and diabetes. This suggests
that increased damage to retinal vessels is associated with increased cognitive impairment.
However, not all studies have supported this [11, 41, 42]. In a sample of middle aged people
without stroke, retinopathy was associated with poorer cognitive function, but smaller AVR
was not [43].
Our study supports the contention that retinal vasculature images are worth considering as
potential risk markers for cognitive decline in people with diabetes, potentially at a relatively
early stage after diagnosis. The link with cognitive function might well be independent of reti-
nopathy, possibly reflecting underlying mechanisms implicated in both T2DM and cognitive
impairment, or underlying mechanisms in T2DM increasing the risk of cognitive impairment.
Further research is needed to confirm our findings, to ascertain the extent to which these mea-
sures predict cognitive decline prospectively, and to ascertain factors accounting for the
observed associations.
Strengths and Limitations
• To our knowledge, this study is the first to investigate associations between measurements
derived from retinal images and cognitive function in newly diagnosed T2DM.
• Cases and controls were drawn from a single cohort and retinal images were rated blind to
case status.
• The sample size was limited and negative findings should be viewed with caution.
Retinal Markers of Microvascular Disease and Cognitive Impairment in Newly Diagnosed Type 2 Diabetes
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• Manual correction of vessel detection potentially subjected the study to a larger degree of
measurement error
• The study was exploratory in nature and the association with venular tortuosity requires rep-
lication in an independent sample.
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(XLSX)
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